Fredun Pharmaceuticals Unveils Premium Hormone Therapeutics Brand

Fredun Pharmaceuticals Limited has announced the launch of its innovative 'HORMONE RANGE PRODUCTS,' a specialty therapeutics brand dedicated to advancing hormone health, longevity, and human performance. This strategic move is aimed at capturing a share of the burgeoning, high-value healthcare sector driven by increasing global demand for preventive and precision-based therapies.

The newly introduced range of products is underscored by a doctor-led, evidence-backed pharmaceutical approach that integrates digital-first patient and doctor engagement tools. This model enhances healthcare delivery, focusing on patient outcomes, adherence, and long-term value to improve life span optimization and preventive care.

Underpinned by Fredun's expertise in pharmaceutical formulation and manufacturing, the brand capitalizes on its robust global distribution network. The initial portfolio includes testosterone-based therapies and growth hormone solutions, catering to specialized clinical needs, and is designed to drive treatment continuity and patient adherence. The company's strategic vision aligns with building a diversified, future-ready healthcare portfolio.

(With inputs from agencies.)